GSE151083 enzalutamide 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE151083_enzalutamide_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE151083_enzalutamide_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE151083_enzalutamide_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE151083_enzalutamide_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

PAX8 antisense RNA 1

Gene

small nucleolar RNA host gene 8

Gene

long intergenic non-protein coding RNA 1963

Gene

uncharacterized LOC339260

Gene

CD27 antisense RNA 1

Gene

HOX transcript antisense RNA

Gene

LBX2 antisense RNA 1

Gene

family with sequence similarity 225 member A

Gene

crystallin zeta like 2, pseudogene

Gene

colorectal cancer associated 1

  • Gene

    PAX8 antisense RNA 1


  • Gene

    small nucleolar RNA host gene 8


  • Gene

    long intergenic non-protein coding RNA 1963


  • Gene

    uncharacterized LOC339260


  • Gene

    CD27 antisense RNA 1


  • Gene

    HOX transcript antisense RNA


  • Gene

    LBX2 antisense RNA 1


  • Gene

    family with sequence similarity 225 member A


  • Gene

    crystallin zeta like 2, pseudogene


  • Gene

    colorectal cancer associated 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.